+ 2.69
+ 1.88%

Why CRISPR Therapeutics Stock Is Trading Higher Today

April 26, 2021 3:52 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Why CRISPR Therapeutics Stock Is Trading Higher Today

CRISPR Therapeutics (NASDAQ:CRSP) shares are trading higher after the company and its partner Vertex Pharmaceuticals announced the EMA granted Priority Medicines designation to CTX001 for the treatment of transfusion-dependent beta thalassemia.

CTX001 is being investigated in two ongoing clinical trials as a potential one-time therapy for patients suffering from TDT and severe SCD.

CRISPR Therapeutics AG is a gene-editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.

The stock was 7.3% higher to $135.80 at the time of writing. The stock has a 52-week high of $220.20 and a 52-week low of $46.84.

Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.


Movers Trading Ideas

Related Articles

CRISPR Therapeutics Shares Rebound From Session Low, Spike Higher On Volume As Hearing Evercore ISI Upgrades Stock To Outperform, Raised Price Target From $52 To $125

Why Voyager Therapeutics, uniQure, Axsome, Reviva Pharma and Crispr Are Moving Today

Voyager Therapeutics, Inc. (NASDAQ: VYGR), uniQure N.V. (NASDAQ: QURE), Axsome Therapeutics, Inc. read more

Why CRISPR Therapeutics Is Trading Higher Today

The Price And Volume Action In CRISPR Therapeutics's Stock Today read more

46 Biggest Movers From Yesterday

Gainers read more